Gene · 9356
Papers1,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research Methods and New Advances in Drug-Drug Interactions Mediated by Renal Transporters. | Molecules | 2023 | 37446913 | PubTator, text mining | PubMed |
A State-of-the-Science Review of Interactions of Per- and Polyfluoroalkyl Substances (PFAS) with Renal Transporters in Health and Disease: Implications for Population Variability in PFAS Toxicokinetics. | Environ Health Perspect | 2023 | 37418334 | PubTator, text mining | PubMed |
| Disulfide-incorporated lipid prodrugs of cidofovir: Synthesis, antiviral activity, and release mechanism. | Eur J Med Chem | 2023 | 37390509 | PubTator, text mining | PubMed |
Improvement of Protein Expression Profile in Three-Dimensional Renal Proximal Tubular Epithelial Cell Spheroids Selected Based on OAT1 Gene Expression: A Potential In Vitro Tool for Evaluating Human Renal Proximal Tubular Toxicity and Drug Disposition. | Drug Metab Dispos | 2023 | 37385755 | PubTator, text mining | PubMed |
| Research progress on the prevention and treatment of hyperuricemia by medicinal and edible plants and its bioactive components. | Front Nutr | 2023 | 37377486 | PubTator, text mining | PubMed |
| Probenecid, an Old Drug with Potential New Uses for Central Nervous System Disorders and Neuroinflammation. | Biomedicines | 2023 | 37371611 | PubTator, text mining | PubMed |
| Using a Graph Convolutional Neural Network Model to Identify Bile Salt Export Pump Inhibitors. | ACS Omega | 2023 | 37360478 | PubTator, text mining | PubMed |
| Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine. | Acta Pharm Sin B | 2023 | 37360014 | PubTator, text mining | PubMed |
| Pharmacokinetics and Drug-Drug Interaction of Ocedurenone (KBP-5074) in vitro and in vivo. | Eur J Drug Metab Pharmacokinet | 2023 | 37357226 | PubTator, text mining | PubMed |
| Association between dietary intake of flavonoids and hyperuricemia: a cross-sectional study. | BMC Public Health | 2023 | 37355562 | PubTator, text mining | PubMed |
| Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis. | Cancer Res | 2023 | 37335130 | PubTator, text mining | PubMed |
| Design Considerations for Pharmacokinetic Studies During Pregnancy. | J Clin Pharmacol | 2023 | 37317491 | PubTator, text mining | PubMed |
| Inhibition of OAT1/3 and CMPF uptake attenuates myocardial ischemia-induced chronic heart failure via decreasing fatty acid oxidation and the therapeutic effects of ruscogenin. | Transl Res | 2023 | 37315712 | PubTator, text mining | PubMed |
| Prognostic Factors for Cardiotoxicity among Children with Cancer: Definition, Causes, and Diagnosis with Omics Technologies. | Diagnostics (Basel) | 2023 | 37296716 | PubTator, text mining | PubMed |
| Detection of potential drug-drug interactions for risk of acute kidney injury: a population-based case-control study using interpretable machine-learning models. | Front Pharmacol | 2023 | 37288110 | PubTator, text mining | PubMed |
| Interlaboratory Variability in the Madin-Darby Canine Kidney Cell Proteome. | Mol Pharm | 2023 | 37283406 | PubTator, text mining | PubMed |
| Pharmacokinetic and pharmacodynamic drug-drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers. | Clin Transl Sci | 2023 | 37282359 | PubTator, text mining | PubMed |
| Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic Modelling. | Pharmaceutics | 2023 | 37242665 | PubTator, text mining | PubMed |
| Fatty Acid-Rich Extract from Holothuria atra for Hyperuricemia via Expressions Modulation of GLUT9a and GLUT9b in Rat Model. | Molecules | 2023 | 37241722 | PubTator, text mining | PubMed |
| Dysuricemia-A New Concept Encompassing Hyperuricemia and Hypouricemia. | Biomedicines | 2023 | 37238926 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9356/papers?page=10